{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:48:23Z","timestamp":1787024903505,"version":"build-2736575974"},"reference-count":36,"publisher":"Informa UK Limited","issue":"14","license":[{"start":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T00:00:00Z","timestamp":1704672000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","award":["Not applicable"],"award-info":[{"award-number":["Not applicable"]}],"id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Oncol."],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.2217\/fon-2023-0271","type":"journal-article","created":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T05:29:53Z","timestamp":1704691793000},"page":"891-901","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":29,"title":["CREST: phase III study of sasanlimab and Bacillus Calmette-Gu\u00e9rin for patients with Bacillus Calmette-Gu\u00e9rin-na\u00efve high-risk non-muscle-invasive bladder cancer"],"prefix":"10.1080","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4469-0624","authenticated-orcid":false,"given":"Gary D","family":"Steinberg","sequence":"first","affiliation":[{"name":"Department of Urology, Rush University Medical Center, Chicago, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neal D","family":"Shore","sequence":"additional","affiliation":[{"name":"Carolina Urologic Research Center, Grand Strand Urology, 823 82nd Parkway, Myrtle Beach, SC29572, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan Palou","family":"Redorta","sequence":"additional","affiliation":[{"name":"Department of Urology, Fundaci\u00f3 Puigvert, Universitat Aut\u00f2noma de Barcelona, C. de Cartagena 340-350, 08025Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew D","family":"Galsky","sequence":"additional","affiliation":[{"name":"The Tisch Cancer Institute, Mount Sinai, 1190 One Gustave L. Levy Place, New York, NY10029, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Bedke","sequence":"additional","affiliation":[{"name":"Department of Urology, Eberhard Karls University T\u00fcbingen, Geschwister-Scholl-Platz, 72074T\u00fcbingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ja Hyeon","family":"Ku","sequence":"additional","affiliation":[{"name":"Department of Urology, Seoul National University Hospital, 101 Daehak-ro Jongno-gu, Seoul03080, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Kretkowski","sequence":"additional","affiliation":[{"name":"Clinical Research Center, Spolka z Ograniczona, Feliksa Nowowiejskiego 5, 61-731Pozna\u0144, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailong","family":"Hu","sequence":"additional","affiliation":[{"name":"Institute of Urology, Second Hospital of Tianjin Medical University, 23 Pingjiang Road, Hexi District, Tianjin300211, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantin","family":"Penkov","sequence":"additional","affiliation":[{"name":"Private Medical Institution Euromedservice, Suvorovskiy Prospekt, 60, St Petersburg, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer J","family":"Vermette","sequence":"additional","affiliation":[{"name":"Pfizer Oncology, Pfizer, 1 Portland Street, Cambridge, MA02139, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamal C","family":"Tarazi","sequence":"additional","affiliation":[{"name":"Pfizer Oncology, Pfizer, 10646 Science Center Drive, San Diego, CA92121, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison E","family":"Randall","sequence":"additional","affiliation":[{"name":"Pfizer Oncology, Pfizer, 235 East 42nd Street, New York, NY10017, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen J","family":"Pierce","sequence":"additional","affiliation":[{"name":"Pfizer Oncology, Pfizer, 280 Shennecossett Road, Groton, CT06340, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Saltzstein","sequence":"additional","affiliation":[{"name":"Division of Urology, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, TX78229, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas B","family":"Powles","sequence":"additional","affiliation":[{"name":"Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London EC1M 5PZ, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,1,8]]},"reference":[{"key":"e_1_3_9_3_1","unstructured":"International Agency for Research on Cancer (IARC). Bladder (2020). Available at: https:\/\/gco.iarc.fr\/today\/data\/factsheets\/cancers\/30-Bladder-fact-sheet.pdf (Accessed: 10January2023)."},{"issue":"1","key":"e_1_3_9_4_1","first-page":"15","article-title":"Epidemiology of bladder cancer","volume":"8","author":"Saginala K","year":"2020","unstructured":"Saginala K , BarsoukA , AluruJS , RawlaP , PadalaSA , BarsoukA. Epidemiology of bladder cancer. Med. Sci. (Basel)8(1), 15 (2020).","journal-title":"Med. Sci. (Basel)"},{"key":"e_1_3_9_5_1","doi-asserted-by":"publisher","DOI":"10.21037\/tau.2018.11.06"},{"key":"e_1_3_9_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2011.10.029"},{"issue":"6","key":"e_1_3_9_7_1","first-page":"CD009294","article-title":"Intravesical gemcitabine for non-muscle invasive bladder cancer","volume":"6","author":"Han MA","year":"2021","unstructured":"Han MA , MaischP , JungJHet al. Intravesical gemcitabine for non-muscle invasive bladder cancer. Cochrane Database Syst. Rev.6(6), CD009294 (2021).","journal-title":"Cochrane Database Syst. Rev."},{"key":"e_1_3_9_8_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2019-0817"},{"key":"e_1_3_9_9_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.3800"},{"key":"e_1_3_9_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2016.05.041"},{"key":"e_1_3_9_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrurol.2014.15"},{"key":"e_1_3_9_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110393"},{"key":"e_1_3_9_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2016.06.049"},{"key":"e_1_3_9_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2021.08.010"},{"key":"e_1_3_9_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2012.10.039"},{"key":"e_1_3_9_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2021.05.015"},{"issue":"7","key":"e_1_3_9_17_1","first-page":"423","article-title":"Failure of Bacillus Calmette-Gu\u00e9rin therapy in non-muscle-invasive bladder cancer: definition and treatment options","volume":"69","author":"Gual Frau J","year":"2016","unstructured":"Gual Frau J , PalouJ , Rodr\u00edguezO , ParadaR , BredaA , VillavicencioH. Failure of Bacillus Calmette-Gu\u00e9rin therapy in non-muscle-invasive bladder cancer: definition and treatment options. Arch. Esp. Urol.69(7), 423\u2013433 (2016).","journal-title":"Arch. Esp. Urol."},{"key":"e_1_3_9_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2015.06.045"},{"key":"e_1_3_9_19_1","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2017.0156"},{"key":"e_1_3_9_20_1","doi-asserted-by":"publisher","DOI":"10.3390\/cells11030357"},{"key":"e_1_3_9_21_1","doi-asserted-by":"publisher","DOI":"10.21037\/tau.2020.02.01"},{"key":"e_1_3_9_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2021.09.018"},{"key":"e_1_3_9_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/bju.15661"},{"key":"e_1_3_9_24_1","doi-asserted-by":"publisher","DOI":"10.3390\/curroncol29050247"},{"key":"e_1_3_9_25_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv009"},{"key":"e_1_3_9_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-018-0022-9"},{"key":"e_1_3_9_27_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.26122"},{"key":"e_1_3_9_28_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2019.37.15_suppl.4550"},{"key":"e_1_3_9_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22588"},{"key":"e_1_3_9_30_1","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S165840"},{"key":"e_1_3_9_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00147-9"},{"key":"e_1_3_9_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2022.02.003"},{"key":"e_1_3_9_33_1","volume-title":"21st Annual Meeting of the Society of Urologic Oncology.","author":"Hahn N","year":"2020","unstructured":"Hahn N , O\u2019DonnellM , EfstathiouJet al. Phase 1 trial of durvalumab in combination with BCG or external beam radiation in BCG-unresponsive non-muscle invasive bladder cancer patients. Presented at: 21st Annual Meeting of the Society of Urologic Oncology.Virtual Meeting (3\u20135 December 2020)."},{"key":"e_1_3_9_34_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-021-03716-3"},{"key":"e_1_3_9_35_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-20-0093"},{"key":"e_1_3_9_36_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2019.0836"},{"key":"e_1_3_9_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.08.1175"},{"key":"e_1_3_9_38_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-158-3-201302050-00583"}],"container-title":["Future Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/fon-2023-0271","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T10:30:29Z","timestamp":1726741829000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/fon-2023-0271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,8]]},"references-count":36,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["10.2217\/fon-2023-0271"],"URL":"https:\/\/doi.org\/10.2217\/fon-2023-0271","relation":{},"ISSN":["1479-6694","1744-8301"],"issn-type":[{"value":"1479-6694","type":"print"},{"value":"1744-8301","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,8]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-03-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-12-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-01-08","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}